Balthaser Kevin 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Balthaser Kevin（CIK 1957554）在 1 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-03-03）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-03-03 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 买入 | 2,375 | $0 |
| 2026-03-03 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 卖出 | 677 | $1,943 |
| 2026-02-05 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 买入 | 22,025 | $0 |
| 2026-02-05 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 卖出 | 6,449 | $22,378 |
| 2026-02-03 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 买入 | 14,750 | $0 |
| 2026-02-03 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 卖出 | 4,984 | $17,494 |
| 2026-01-05 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 买入 | 73,750 | $0 |
| 2026-01-05 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 卖出 | 19,934 | $60,001 |
| 2026-01-05 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 买入 | 7,500 | $0 |
| 2026-01-05 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 卖出 | 2,250 | $6,772 |
| 2026-01-05 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 买入 | 13,200 | $0 |
| 2026-01-05 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 卖出 | 4,461 | $12,848 |
来源：SEC Form 4 申报文件 · 截至 2026-03-03